Seqirus USA INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.6Mgeneral payments (2019-2025)
$69Kresearch payments (2019-2025)
19,804clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Archana Chatterjee | Sioux Falls, SD | Pediatric Infectious Diseases | $66,086.15 |
| Christoph Correll | Glen Oaks, NY | Psychiatry | $63,467.25 |
| Stephen Pelton | Boston, MA | Pediatric Infectious Diseases | $46,183.50 |
| Donald Middleton | Pittsburgh, PA | Internal Medicine | $42,438.32 |
| Gary Marshall | Louisville, KY | Pediatric Infectious Diseases | $41,222.13 |
| Judith Wolf | Philadelphia, PA | Infectious Disease | $37,975.00 |
| Matthew Weir | Baltimore, MD | Nephrology (Internal Medicine) | $35,671.43 |
| Darvin Smith | Redwood City, CA | Infectious Disease | $30,718.65 |
| Myron Levin | Aurora, CO | Pediatric Infectious Diseases | $30,235.72 |
| Matthew Budoff | Torrance, CA | Cardiovascular Disease | $26,990.92 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.